Estradiol transdermal patches market is anticipated to grow at a significant CAGR during the forecast period. Estradiol is a form of estrogen which is a female sex hormone produced by the ovaries necessary for many processes in the body. Additionally, estradiol transdermal patches are used for the treatment of certain symptoms of menopause such as hot flashes, vaginal dryness, burning, and irritation. The major factor driving the demand for estradiol transdermal patches is the new product launches and drug approval across the globe.
For instance, in December 2020, Agile Therapeutics, Inc. announced the launch of the Twirla (levonorgestrel and Ethinyl estradiol) transdermal system in the US. It is a non-daily, non-invasive contraceptive patch available by prescription for women of reproductive potential with a body mass index (BMI) <30 kg/m2 for whom a combined hormonal contraceptive is appropriate to prevent pregnancy. Furthermore, the market is also growing due to the increasing application of these patches in males and females for treatment.
Some major players in the market include Novartis International AG, Bayer AG, and Johnson & Johnson Services, Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in February 2021, Amneal Pharmaceuticals, Inc. announced the approval of Abbreviated New Drug Application (ANDA) for 150 mcg/day Norelgestromin and 35 mcg/day Ethinyl Estradiol Transdermal System from the US Food and Drug Administration (FDA). Additionally, the company also received a Competitive Generic Therapy (CGT) designation with 180 days of exclusivity.
To Request a Sample of our Report on Estradiol Transdermal Patches Market: https://www.omrglobal.com/request-sample/estradiol-transdermal-patches-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Novartis International AG, Bayer AG, and Johnson & Johnson Services, Inc., among others.
Estradiol Transdermal Patches Market Report by Segment
By Type
- 25 mg/day
- 50 mg/day
- 75 mg/day
- 100 mg/day
By Application
- Male
- Female
A full Report of Estradiol Transdermal Patches Market is Available @ https://www.omrglobal.com/industry-reports/estradiol-transdermal-patches-market
Estradiol Transdermal Patches Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
